We
have investigated both batch and continuous flow photoarylations of
enol-acetates to yield different α-arylated aldehyde and ketone
building blocks by using diazonium salts as the aryl-radical source.
Different porphyrins were used as SET photocatalysts, and photophysical
as well as electrochemical studies were performed to rationalize the
photoredox properties and suggest mechanistic insights. Notably, the
most electron-deficient porphyrin (meso-tetra(pentafluorophenyl)porphyrin)
shows the best photoactivity as an electron donor in the triplet excited
state, which was rationalized by the redox potentials of excited states
and the turnover of the porphyrins in the photocatalytic cycle. A
two-step continuous protocol and multigram-scale reactions are also
presented revealing a robust, cost-competitive, and easy methodology,
highlighting the significant potential of porphyrins as SET photocatalysts.
We present a comprehensive review of the advent and impact of continuous flow chemistry with regard to the synthesis of natural products and drugs, important pharmaceutical products and definitely responsible for a revolution in modern healthcare. We detail the beginnings of modern drugs and the large scale batch mode of production, both chemical and microbiological. The introduction of modern continuous flow chemistry is then presented, both as a technological tool for enabling organic chemistry, and as a fundamental research endeavor. This part details the syntheses of bioactive natural products and commercial drugs.
Chagas disease is included in the neglected tropical diseases list and is endemic to 21 Latin American countries. The two drugs currently available for treating Chagas disease are nifurtimox and benznidazole and both result in many significant side effects. The study describes the synthesis and biological evaluation of 3,5-disubstituted isoxazoles. Isoxazoles were obtained by reaction of flavones and hydroxylamine and either alkylated at the free hydroxyl group and/or nitrated at the isoxazole ring. These compounds were evaluated for their in vitro anti-Trypanosoma cruzi activity against trypomastigote and amastigote forms of the parasite in T. cruzi-infected cell lineages. Benznidazole was used as a reference compound for the in vitro assay and mammalian L929 cells were employed to evaluate cytotoxicity. A majority of the compounds tested were very active and the most active isoxazole against amastigote and trypomastigotes of T. cruzi was slightly more potent than the current medicine benznidazole.
We investigated the electrochemical
sulfenylation reaction in both
batch and continuous flow regimes, involving thiophenols/thiols and
enol–acetates to yield α-sulfenylated ketones, without
using additional oxidants or catalysts. Studies with different electrolytes
were also performed, revealing that quaternary ammonium salts are
the best mediators for this reaction. Notably, during the study of
the reaction scope, a Boc-cysteine proved to be extremely tolerant
to our protocol, thus increasing its relevance. The methodology also
proved to be scalable in both batch and continuous flow conditions,
opening up possibilities for further studies since these relevant
functional groups are important moieties in organic synthesis.
This chapter presents the major impacts of continuous flow technologies on the development of syntheses of bioactive natural product molecules and active pharmaceutical ingredients (APIs). We emphasize scalable and robust protocols covering the literature from 2015 to mid-2020. In the case of continuous manufacturing of APIs we decided to cover examples with relevance considering the advanced stage for industrial production, the molecular complexity, and the importance of each API for Big Pharma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.